Article
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults
2023-02-18
Abstract excerpt
Antibodies are used to estimate prevalence of past infection. However, T cell responses against SARS-CoV-2 may more accurately define prevalence because SARS-CoV-2-specific antibodies wane. In November-December 2021, we studied serological and cellular immune responses in residents of rural Kenya who had not experienced any respiratory symptom nor had contact with COVID-19 cases. Among participants we detected ant...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bce40aa4-33e6-505f-9a31-5d37a291c4c0
- DOI
- 10.1101/2023.02.17.23286075
